Author rebuttal to response regarding “Letter to the Editor regarding ‘Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?’”

In response to comments published by Timothy Fernandes et al. to our Letter to the Editor titled “Could pulmonary arterial hypertension patients be at a lower risk from severe COVID-19?,”1 we believe it is critical to provide additional information and perspective. Fernandes et al. expressed concern that our survey data of pulmonary arterial hypertension (PAH) and CTEPH patients represented only a snapshot early in the COVID-19 pandemic when the U.S. was at the beginning stages of disease acceleration, and testing was limited. We agree with this observation and have extended our survey window through 6 May 2020, past the peak of COVID activity in much of the U.S. At the end of the survey period, we received a total of 86 responses by PH health care providers, with 66% estimating that their sites had more than 100 PAH and CTEPH patients strengthening our conclusions.

 

Read the full article online

Topics

Pulmonary Arterial Hypertension

Authors

Evelyn Horn, Murali M. Chakinala, Ronald Oudiz, Elizabeth Joseloff, Erika B. Rosenzweig

Published in:

Pulmonary Circulation Vol 10: No 3 cover image

July 2020

Pulmonary Circulation Vol 10: No 3

View this journal

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI
standard-example-image.jpg